Kura Oncology, Inc. (KURA) Position Maintained by Boxer Capital LLC

Boxer Capital LLC maintained its position in shares of Kura Oncology, Inc. (NASDAQ:KURA) during the first quarter, Holdings Channel reports. The fund owned 533,251 shares of the company’s stock at the end of the first quarter. Kura Oncology makes up about 1.0% of Boxer Capital LLC’s holdings, making the stock its 15th largest position. Boxer Capital LLC’s holdings in Kura Oncology were worth $4,693,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of KURA. Geode Capital Management LLC increased its position in shares of Kura Oncology by 0.9% in the first quarter. Geode Capital Management LLC now owns 49,682 shares of the company’s stock worth $437,000 after buying an additional 426 shares during the period. Oppenheimer & Co. Inc. increased its position in shares of Kura Oncology by 14.7% in the first quarter. Oppenheimer & Co. Inc. now owns 12,500 shares of the company’s stock worth $110,000 after buying an additional 1,600 shares during the period. Renaissance Technologies LLC increased its position in shares of Kura Oncology by 25.4% in the fourth quarter. Renaissance Technologies LLC now owns 30,600 shares of the company’s stock worth $181,000 after buying an additional 6,200 shares during the period. Vanguard Group Inc. increased its position in shares of Kura Oncology by 2.3% in the first quarter. Vanguard Group Inc. now owns 383,835 shares of the company’s stock worth $3,378,000 after buying an additional 8,619 shares during the period. Finally, Segantii Capital Management Ltd purchased a new position in shares of Kura Oncology during the first quarter worth approximately $120,000. Hedge funds and other institutional investors own 50.19% of the company’s stock.

Institutional Ownership by Quarter for Kura Oncology (NASDAQ:KURA)

Kura Oncology, Inc. (KURA) remained flat at $7.95 during mid-day trading on Friday. The stock had a trading volume of 22,655 shares. The company’s 50 day moving average is $9.01 and its 200-day moving average is $7.78. The company’s market cap is $156.35 million. Kura Oncology, Inc. has a 1-year low of $2.50 and a 1-year high of $12.10.

Kura Oncology (NASDAQ:KURA) last announced its quarterly earnings data on Monday, May 15th. The company reported ($0.39) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.44) by $0.05. Equities analysts predict that Kura Oncology, Inc. will post ($1.63) earnings per share for the current year.

TRADEMARK VIOLATION WARNING: This report was originally published by WKRB News and is the sole property of of WKRB News. If you are reading this report on another domain, it was copied illegally and reposted in violation of international trademark & copyright laws. The correct version of this report can be read at https://www.wkrb13.com/markets/2228921/kura-oncology-inc-kura-position-maintained-by-boxer-capital-llc.html.

A number of research analysts have commented on the company. Zacks Investment Research upgraded Kura Oncology from a “strong sell” rating to a “hold” rating in a research note on Wednesday, April 12th. Oppenheimer Holdings, Inc. set a $16.00 price target on Kura Oncology and gave the stock a “buy” rating in a research note on Wednesday. Finally, Cann reiterated a “buy” rating and set a $16.00 price target on shares of Kura Oncology in a research note on Monday, May 15th.

Kura Oncology Company Profile

Kura Oncology, Inc is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing personalized therapeutics for the treatment of solid tumors and blood cancers. Its segment is engaged in the discovery and development of personalized therapeutics for the treatment of solid tumors and blood cancers.

Want to see what other hedge funds are holding KURA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kura Oncology, Inc. (NASDAQ:KURA).

This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2228921/kura-oncology-inc-kura-position-maintained-by-boxer-capital-llc.html

Receive News & Ratings for Kura Oncology Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kura Oncology Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

 


Leave a Reply

 
© 2006-2017 WKRB News.